GHP Specialty Care AB
F:2BQ
Relative Value
There is not enough data to reliably calculate the relative value of 2BQ.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
2BQ Competitors Multiples
GHP Specialty Care AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
G
|
GHP Specialty Care AB
F:2BQ
|
230.1m EUR | 1.6 | 44.6 | 12.5 | 27.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
101.2B USD | 0.3 | 57.2 | 14.4 | 14.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
64.9B EUR | 0.3 | 12.4 | 7.9 | 10.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
77.2B USD | 0.3 | 12.6 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.1B EUR | 1.2 | 22.6 | 10.4 | 15.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.3B EUR | 1.2 | 23.4 | 9 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.7B USD | 1.7 | 27 | 12.9 | 18.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23.4B USD | 2.1 | 23.6 | 12.9 | 17.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.3 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.3B USD | 12.5 | -29.6 | -31.7 | -28.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.7B USD | 0.8 | 14.4 | 7.4 | 10.1 |